• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial.

作者信息

Wilson Hope P, Mosha Maua, Miller Alexandra, Betensky Marisol, Amankwah Ernest, Fargo John, Thornburg Courtney D, Tarango Cristina, Acharya Suchitra, Male Christoph, Narang Shalu, Schulman Sam, Goldenberg Neil A

机构信息

Department of Pediatrics, University of Alabama at Birmingham Heersink School of Medicine and Children's of Alabama, Birmingham, Alabama.

Department of Health Informatics, Data Coordinating Center for Pediatric Multicenter Studies, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida.

出版信息

Semin Thromb Hemost. 2025 Apr;51(3):343-347. doi: 10.1055/s-0044-1790572. Epub 2024 Sep 19.

DOI:10.1055/s-0044-1790572
PMID:39299256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11908955/
Abstract
摘要

相似文献

1
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial.21岁以下患者原发性抗凝治疗后发生的诱因型静脉血栓栓塞的二级抗凝治疗：儿童DOTT试验的结果
Semin Thromb Hemost. 2025 Apr;51(3):343-347. doi: 10.1055/s-0044-1790572. Epub 2024 Sep 19.
2
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.抗凝治疗 6 周与 3 个月对 21 岁以下有诱因的静脉血栓栓塞症患者的复发和出血事件的影响：Kids-DOTT 随机临床试验。
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
3
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial.21岁以下患者诱发性急性脑静脉窦血栓形成的临床特征、治疗及结局：儿童DOTT多国试验的结果
Res Pract Thromb Haemost. 2024 Oct 23;8(7):102605. doi: 10.1016/j.rpth.2024.102605. eCollection 2024 Oct.
4
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.儿童静脉血栓栓塞抗凝治疗的持续时间：儿童血栓形成治疗持续时间评估（Kids-DOTT）试验2年的结果
J Thromb Haemost. 2025 Feb;23(2):651-656. doi: 10.1016/j.jtha.2024.09.038. Epub 2024 Oct 24.
5
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.儿童和青年血栓形成治疗持续时间的多中心随机对照试验（儿童-DOTT试验）：试点/可行性阶段结果
J Thromb Haemost. 2015 Sep;13(9):1597-605. doi: 10.1111/jth.13038. Epub 2015 Aug 11.
6
Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.儿童静脉血栓栓塞症抗凝治疗的持续时间：当前方法及随机对照试验的更新情况
Expert Rev Hematol. 2018 Jan;11(1):37-44. doi: 10.1080/17474086.2018.1407241. Epub 2017 Dec 17.
7
Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism.小儿中心静脉导管相关静脉血栓栓塞症抗凝治疗6周与3个月的比较
J Pediatr Hematol Oncol. 2017 Oct;39(7):518-523. doi: 10.1097/MPH.0000000000000920.
8
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.伴有获得性静脉血栓形成和抗磷脂抗体的儿童的结局：来自 Kids-DOTT 试验的结果。
Blood Adv. 2024 Nov 26;8(22):5790-5795. doi: 10.1182/bloodadvances.2024014415.
9
Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank.血浆纤维蛋白溶解、炎症标志物与血栓后综合征：Kids-DOTT 生物样本库的初步发现。
Blood Adv. 2021 Jan 12;5(1):233-239. doi: 10.1182/bloodadvances.2020002974.
10
Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.儿童急性静脉血栓栓塞症的延长阶段抗凝治疗：来自EINSTEIN-Jr 3期试验的队列研究
Lancet Haematol. 2025 May;12(5):e357-e364. doi: 10.1016/S2352-3026(25)00067-5. Epub 2025 Apr 10.

本文引用的文献

1
Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium.有既往静脉血栓栓塞病史的住院儿童复发性静脉血栓栓塞：儿童医院获得性血栓形成联盟的报告
Res Pract Thromb Haemost. 2023 Jun 29;7(5):102139. doi: 10.1016/j.rpth.2023.102139. eCollection 2023 Jul.
2
Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability.深静脉血栓形成对青少年运动员的影响：应对一种无形的残疾。
Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12779. doi: 10.1002/rth2.12779. eCollection 2022 Jul.
3
Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey.儿科继发性血栓形成预防的实践模式：一项国际调查的结果。
Res Pract Thromb Haemost. 2022 Apr 7;6(3):e12693. doi: 10.1002/rth2.12693. eCollection 2022 Mar.
4
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.抗凝治疗 6 周与 3 个月对 21 岁以下有诱因的静脉血栓栓塞症患者的复发和出血事件的影响：Kids-DOTT 随机临床试验。
JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182.
5
Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis.预防中心静脉导管相关性静脉血栓形成患儿的复发性血栓事件。
Blood. 2022 Jan 20;139(3):452-460. doi: 10.1182/blood.2021013453.
6
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.达比加群酯在儿童中的静脉血栓栓塞症二级预防中的安全性。
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
7
Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.高危血栓形成倾向状态对首例非中心静脉导管相关静脉血栓栓塞症儿童复发的影响：一项观察性多中心队列研究。
Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192. Epub 2016 Jun 22.
8
The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children.依诺肝素治疗的质量和持续时间对儿童复发性静脉血栓的影响。
Pediatr Blood Cancer. 2012 Jul 15;59(1):105-9. doi: 10.1002/pbc.23396. Epub 2011 Nov 21.
9
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.遗传性血栓形成倾向对儿童静脉血栓栓塞的影响：观察性研究的系统评价和荟萃分析
Circulation. 2008 Sep 23;118(13):1373-82. doi: 10.1161/CIRCULATIONAHA.108.789008. Epub 2008 Sep 8.
10
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.儿童静脉血栓栓塞并发症（VTE）：加拿大VTE注册研究的首次分析
Blood. 1994 Mar 1;83(5):1251-7.